Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Merit on the deal. Merit, a verified identity platform, announced its $50 million Series B financing. Rose Park Advisors led the financing round...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Amunix on the deal, while Weil, Gotshal & Manges advised Sanofi. Amunix, an immuno-oncology company, announced its pending acquisition by Sanofi, a global...
You must be a Standard 1 Year member to access this content.
Fenwick & West advised Kareo on the deal while Cooley LLP represented PatientPop. Kareo, a cloud-based healthcare technology platform, announced its merger with PatientPop, a leader in...
You must be a Standard 1 Year member to access this content.
Fenwick advised Conversa Health, while Ropes & Gray advised Amwell in the transaction. Amwell® (NYSE: AMWL), a national telehealth leader, has signed definitive agreements to acquire SilverCloud Health,...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Chinook Therapeutics, Inc. on the deal. Chinook Therapeutics, Inc. (NASDAQ: KDNY), a clinical-stage biotechnology company developing precision medicines for kidney diseases,...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new targeted therapies for children...
You must be a Standard 1 Year member to access this content.
